Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. (Q34022670)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. |
scientific article |
Statements
1 reference
Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. (English)
1 reference
Roland Buhl
1 reference
Ronald Dahl
1 reference
Kian Fan Chung
1 reference
Helgo Magnussen
1 reference
Vladimir Nonikov
1 reference
Damon Jack
1 reference
Patricia Bleasdale
1 reference
Roger Owen
1 reference
Mark Higgins
1 reference
Benjamin Kramer
1 reference
INVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study Investigators
1 reference
Identifiers
1 reference